
News
The Nasdaq Biotechnology Index closed down 0.85%. Component stock Lyell Immunopharma fell 12.87%, Summit Therapeutics Plc. dropped 11.32%, and Ironwood Pharmaceuticals declined 9.69%, making it the third largest decline. LENZ Therapeutics rose 6.84%, ranking third in performance, Insmed increased by 7.75%, and Tevogen Bio Holdings also rose by 8.06%
